Current Issues and Ongoing Challenges in MS: Neurodegeneration and Neuroprotection
The contents of this issue of Johns Hopkins Advanced Studies in Medicine include proceedings from The 6th Annual Johns Hopkins MS Symposium held in Washington, DC, on March 7, 2009.
Activity Date: July 2009  — Activity Info: Volume 9, (2)
 

Full Disclosure Policy Affecting CME Activities:
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing to require the disclosure of the existence of any relevant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation.

Policy on Faculty and Provider Disclosure

It is the policy of The Institute for Johns Hopkins Nursing to require our continuing nursing education faculty and planning committee members to disclose any financial relationships with companies providing program funding or manufacturers of any commercial products discussed in the educational activity. The Course Directors and Participating Faculty reported the following:

COURSE DIRECTORS

Arun Venkatesan, MD, PhD
Assistant Professor of Neurology
Department of Neurology
The Johns Hopkins Medical Institute
Baltimore, Maryland
Dr Venkatesan reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

Michael K. Racke, MD
Professor and Chairman of Neurology
The Helen C. Kurtz Chair in Neurology
The Ohio State University Medical Center
Columbus, Ohio
Dr Racke reports serving as a consultant for Bristol-Myers Squibb Company, Peptimmune, Inc, and Teva Neuroscience; and serving on the speakers' bureau for Genentech, Inc.

Faith H. Howarth, MSN, EdM, CRNP, CS
Clinical Faculty
Johns Hopkins University School of Nursing
Baltimore, Maryland
Ms Howarth reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

NURSE PLANNER

Jane C. Shivnan, MScN, RN, AOCN
Executive Director, Institute for Johns Hopkins Nursing
Baltimore, Maryland
Ms Shivnan reports having no relationships with commercial interests related to this activity.

PARTICIPATING FACULTY

Peter A. Calabresi, MD
Professor of Neurology
Director, Multiple Sclerosis Center
The Johns Hopkins Hospital
Baltimore, Maryland
Dr Calabresi reports receiving grants/research support from Biogen Idec, Genentech, Inc, Serono, Teva Neuroscience, and Vertex Pharmaceuticals; and receiving honoraria from and serving as a consultant for Amplimmune, Inc, Biogen Idec, Centocor, Inc, Genentech, Inc, Novartis Pharmaceuticals Corporation, Serono, Teva Neuroscience, and Vertex Pharmaceutials.

Benjamin Greenberg, MD, MHS
Director, Transverse Myelitis and Neuromyelitis Optica Program
Deputy Director, Multiple Sclerosis Program
Cain Denius Scholar in Mobility Disorders
Department of Neurology
University of Texas Southwestern
Dallas, Texas
Dr Greenberg reports receiving grants/research support from Accelerated Cure Project, National Multiple Sclerosis Society, and Novartis Pharmaceuticals Corporation; serving as a consultant for and holding stock in DioGenix; and receiving honoraria from Biogen Idec and Teva Neuroscience.

Clyde E. Markowitz, MD
Associate Professor of Neurology
Director, Multiple Sclerosis Center
The Hospital of the University of Pennsylvania
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Dr Markowitz reports receiving grants/research support from Bayer, Biogen Idec, BioMS, EMD Serono, Inc, Genentech, Inc, Novartis Pharmaceuticals Corporation, and Teva; serving as a consultant for Bayer, Biogen Idec, BioMS, EMD Serono, Inc, Genentech, Inc, and Novartis Pharmaceuticals Corporation; receiving honoraria from Bayer, Biogen Idec, EMD Serono, Inc, and Teva; and serving on the speakers' bureau for Bayer, Biogen Idec, and EMD Serono, Inc.

Bruce D. Trapp, PhD
Chairman, Department of Neurosciences
Lerner Research Institute
Cleveland Clinic
Cleveland, Ohio
Dr Trapp reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Notice: The audience is advised that articles in this CME/CNE activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices.

Dr Greenberg—alemtuzumab, BG-12, cladribine, cyclophosphamide, daclizumab, fingolimod, laquinomod, rituximab, and teriflunomide.
Dr Racke—rituximab and other agents for treatment of neuromyelitis optica.

All other faculty have indicated that they have not referenced unlabeled or unapproved uses of drugs or devices.

Non-Endorsement of Products

The Institute for Johns Hopkins Nursing does not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.

     
Home | Contact Us | View Account | Need Help? | Subscription